Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Ertapenem Sodium Salt: Applied Workflows for Antibiotic R...

    2026-04-09

    Ertapenem Sodium Salt: Advanced Workflows and Troubleshooting for Resistance Research

    Introduction: Principle and Potency of Ertapenem (Sodium Salt)

    Ertapenem (sodium salt) stands at the vanguard of broad-spectrum carbapenem antibiotics, targeting a wide array of Gram-positive, Gram-negative, aerobic, and anaerobic bacteria. Its mechanism hinges on potent inhibition of bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), notably PBPs 2 and 3 in Escherichia coli. This rapid, bactericidal action makes Ertapenem sodium salt the agent of choice for experimental workflows focused on antibiotic resistance, cell viability, and pharmacokinetics of ertapenem. As a water-soluble, stable compound (≥52 mg/mL in water), it is specifically engineered for laboratory research and not for diagnostic or clinical use.

    Recent surveillance studies, such as the 2022–2024 Guangdong multi-hospital analysis, have underscored the critical need for robust carbapenem agents amid rising multidrug-resistant Enterobacteriaceae. In these scenarios, precise antimicrobial evaluation using Ertapenem sodium salt is indispensable for assessing resistance phenotypes, tracking transmission dynamics, and informing stewardship strategies.

    Step-by-Step Workflow Enhancements with Ertapenem (Sodium Salt)

    1. Preparation and Storage

    • Dissolve Ertapenem sodium salt in sterile water to a working stock concentration (≥52 mg/mL). For certain applications, DMSO may be used with ultrasonic assistance; ethanol is not recommended due to insolubility.
    • Aliquot and store at -20°C to preserve stability; avoid repeated freeze-thaw cycles. Use freshly prepared solutions for cell-based assays to minimize degradation.

    2. Minimum Inhibitory Concentration (MIC) Determination

    1. Prepare serial dilutions of Ertapenem sodium salt in appropriate broth (e.g., Mueller-Hinton for aerobic bacteria).
    2. Dispense into 96-well plates; inoculate with standardized bacterial suspensions (0.5 McFarland standard, ~1x105 CFU/mL).
    3. Incubate at 35°C for 16–20 hours.
    4. Assess growth visually or via OD600 readings. The MIC is the lowest concentration showing complete inhibition.

    Notably, MIC90 values for most Enterobacteriaceae are <1 mg/L, making Ertapenem sodium salt a sensitive marker for emerging resistance phenotypes.

    3. Resistance Profiling and Synergy Testing

    • Combine Ertapenem with other antibiotics (e.g., ceftazidime/avibactam, gentamicin) in checkerboard or time-kill assays to evaluate synergistic or antagonistic interactions.
    • Apply sodium dodecyl sulfate (SDS) plasmid elimination methods and PCR to correlate resistance determinants with phenotypic data, as demonstrated in the Guangdong study (Chen et al., 2025).

    4. Cell Viability and Cytotoxicity Assays

    • Use Ertapenem sodium salt to establish dose-response curves in mammalian or bacterial cell culture systems.
    • Quantify cell viability post-treatment using MTT, resazurin, or similar metabolic assays; normalize results to untreated controls.

    For a practical deep-dive into these protocols, "Ertapenem (sodium salt): Precise Solutions for Cell Assay..." complements this workflow by providing scenario-driven guidance on optimizing assay reproducibility and compatibility.

    Advanced Applications and Comparative Advantages

    1. Surveillance of Resistance Dynamics

    The Guangdong reference study (Chen et al., 2025) exemplifies how Ertapenem sodium salt is central to the detection and characterization of carbapenemase-encoding genes (CEGs), such as blaNDM-1 and blaKPC-2, in carbapenem-resistant Enterobacter cloacae. The study reported:

    • 85.2% of isolates positive for CEGs, with multidrug resistance rates significantly elevated compared to CEG-negative strains.
    • MIC-based profiling revealed resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin were all markedly higher in CEG-positive isolates (P<0.05).

    By integrating Ertapenem sodium salt into high-throughput screening, researchers can rapidly identify resistance trends, facilitating both epidemiological surveillance and experimental validation of novel resistance mechanisms.

    2. Benchmarking Against Other Carbapenems

    Compared to other carbapenem antibiotics, Ertapenem sodium salt offers pronounced stability, a longer plasma half-life (3.8–4.4 hours), and favorable pharmacokinetics with 45% renal clearance. Its spectrum covers both Gram-positive and Gram-negative bacteria, but with improved efficacy against Enterobacteriaceae and anaerobes. This makes it an ideal reference for comparative studies or for delineating subtle resistance mechanisms in multi-species panels.

    For a broader perspective, "Optimizing Cell-Based Assays with Ertapenem (sodium salt)..." extends these findings by focusing on assay reproducibility and compatibility in sensitive, high-throughput laboratory settings.

    3. Translational Resistance Research and Mobile Genetic Elements

    Ertapenem sodium salt is invaluable for dissecting the transmission dynamics of resistance determinants. The Guangdong study leveraged plasmid conjugation experiments, revealing a 95.7% success rate for transfer of CEGs, with ISEcp1 as the most prevalent mobile element (87% of isolates). Such insights are critical when deploying Ertapenem as a selection agent in experimental evolution, horizontal gene transfer, or molecular epidemiology studies.

    For a strategic overview, "Ertapenem (Sodium Salt): Strategic Mechanisms and Transla..." complements this article by exploring the integration of Ertapenem in translational workflows and antibiotic stewardship programs.

    Common Troubleshooting and Optimization Tips

    • Solubility Issues: Ensure Ertapenem sodium salt is fully dissolved in water (≥52 mg/mL). For higher concentrations, employ gentle heating or ultrasonic assistance if using DMSO. Avoid ethanol.
    • Solution Stability: Prepare fresh working solutions just before use. Store aliquots at -20°C for short-term needs; discard after repeated freeze-thaw cycles.
    • Assay Variability: Standardize inoculum densities and incubation times. Include positive (sensitive) and negative (resistant) control strains in every batch to ensure MIC accuracy.
    • Unexpected Resistance: Confirm strain identity and resistance genotype by PCR or sequencing. In multidrug-resistant panels, consider potential efflux or permeability mutations that could affect apparent susceptibility to Ertapenem sodium salt.
    • Data Interpretation: Reference established clinical breakpoints where applicable, but interpret results within the context of research (not diagnostic) use. The presence of carbapenemase-encoding genes (e.g., blaNDM-1) can confer high-level resistance even at low Ertapenem concentrations.

    For more troubleshooting strategies, "Ertapenem (sodium salt): Data-Driven Solutions for Reliab..." offers scenario-based advice for optimizing reproducibility and minimizing experimental pitfalls across diverse bacterial phenotypes.

    Future Outlook: Ertapenem Sodium Salt in Resistance Surveillance and Beyond

    As antibiotic resistance continues to evolve, Ertapenem sodium salt remains integral to both fundamental and translational research. The robust data from the Guangdong surveillance study highlights the compound's relevance for monitoring resistance gene dissemination, particularly in high-risk patient populations and clinical departments. Advances in high-throughput genomics and automated phenotyping will further amplify the utility of Ertapenem as a reference antibacterial agent for Gram-positive and Gram-negative bacteria, enabling faster, more precise interventions against multidrug-resistant threats.

    Looking ahead, the integration of Ertapenem sodium salt with omics technologies, real-time resistance tracking, and next-generation cell viability platforms will open new avenues in antibiotic resistance research, stewardship, and drug discovery. As a trusted supplier, APExBIO remains committed to supporting these innovations with high-purity, rigorously validated Ertapenem sodium salt for reproducible, insightful bench science.

    Product Resource

    For detailed specifications, storage guidelines, and ordering information, visit the Ertapenem (sodium salt) product page at APExBIO.